Why is Bliss GVS Pharma falling/rising?

As of 25-Jul, Bliss GVS Pharma Ltd's stock price is currently at 154.30, reflecting an increase of 1.15 (0.75%). Today, the stock has shown a positive trend, gaining after four consecutive days of decline, and opened with a gain of 2.51%. It reached an intraday high of Rs 157, indicating a strong start to the trading day. Despite this positive movement, the stock has experienced a decline of 4.40% over the past week and a year-to-date drop of 6.29%. However, it has outperformed the BSE500 over the last year with a return of 29.55%, although its profits have decreased by 19.5%. The stock's fair valuation, indicated by a Price to Book Value of 1.5 and a low Debt to Equity ratio, suggests stability, which may contribute to its recent upward movement.
In the broader market context, the stock's performance over the past week contrasts with the Sensex, which has only declined by 0.36%. This indicates that while Bliss GVS Pharma has faced short-term challenges, its long-term performance remains strong, particularly over the last three years where it has outperformed the benchmark significantly. The stock's recent gains, despite falling investor participation and lower delivery volumes, suggest that it may be attracting renewed interest from investors looking for value in a market where it has historically performed well.